Predictors of 1- and 12-month mortality in bifurcation coronary intervention: a contemporary perspective.
Majd B ProttyTom ValenzuelaAhmed SharafJoy ShomeSaad HasanAlexander ChaseZia UlHaqAdrian IonescuAyush KhuranaGeraint JenkinsDaniel R ObaidAnirban ChoudhuryAhmed HailanPublished in: Future cardiology (2023)
Aim: Bifurcation-PCI is performed frequently, although without extensive evidence to back up a definitive solution for its complexity. We set out to identify factors associated with 1- and 12-month mortality after bifurcation-PCI between 2017 and 2021 in our tertiary centre in Wales, UK. Results: Of 732 bifurcation PCI cases (mean age 69; 25% female), 67% were in ACS, 42% were left main PCI and 25.3% involved two-stent strategy. 30-day and 12-month mortality were 1.9% and 8.2%, respectively. Age, diabetes, smoking and renal failure are associated with mortality after bifurcation-PCI, while the choice between provisional and 2-stent strategies did not impact mortality/TLR. Conclusion: Awareness of 'real-world' outcomes of bifurcation-PCI should be used for appropriate patient selection, technique planning and procedural consent.
Keyphrases
- coronary artery disease
- acute coronary syndrome
- percutaneous coronary intervention
- cardiovascular events
- acute myocardial infarction
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- endovascular treatment
- atrial fibrillation
- coronary artery bypass grafting
- type diabetes
- randomized controlled trial
- risk factors
- cardiovascular disease
- inflammatory response
- immune response
- squamous cell carcinoma
- coronary artery
- toll like receptor
- skeletal muscle
- adipose tissue
- heart failure
- case report
- coronary artery bypass
- locally advanced